MICHAEL WHITLEDGE: Open Payments
NPI 1174852149 · SAVANNAH, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,265 in 118 payments from 28 companies in 2025. Trend: 2023 $2,612 · 2024 $2,042 · 2025 $2,265
Food & beverage: $2,265
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $383 |
| ABBVIE INC. | 20 | $298 |
| Axsome Therapeutics, Inc. | 12 | $286 |
| Novo Nordisk Inc | 16 | $256 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $87 |
| Novartis Pharmaceuticals Corporation | 4 | $87 |
| HARMONY BIOSCIENCES LLC | 4 | $87 |
| Amgen Inc. | 5 | $85 |
| PFIZER INC. | 4 | $83 |
| Lilly USA, LLC | 3 | $79 |
Products named: Auvelity, VRAYLAR, FARXIGA, AIRSUPRA, Ozempic, Wegovy, CAPLYTA, LEQVIO.
Industry payments across GA — which companies pay providers there.
